Yahoo Finance7 小时
Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab ...
- Late-breaking data presentation at ASH will feature results from the Phase 3 inMIND study evaluating tafasitamab in ...